[go: up one dir, main page]

NO932127D0 - Imidatderivater av farmasoeytisk nyttige antikonvulserendesulfamater - Google Patents

Imidatderivater av farmasoeytisk nyttige antikonvulserendesulfamater

Info

Publication number
NO932127D0
NO932127D0 NO932127A NO932127A NO932127D0 NO 932127 D0 NO932127 D0 NO 932127D0 NO 932127 A NO932127 A NO 932127A NO 932127 A NO932127 A NO 932127A NO 932127 D0 NO932127 D0 NO 932127D0
Authority
NO
Norway
Prior art keywords
pharmasoeytic
anticonvulsing
sulfamates
useful
imidate derivatives
Prior art date
Application number
NO932127A
Other languages
English (en)
Other versions
NO301073B1 (no
NO932127L (no
Inventor
Bruce E Maryanoff
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of NO932127D0 publication Critical patent/NO932127D0/no
Publication of NO932127L publication Critical patent/NO932127L/no
Publication of NO301073B1 publication Critical patent/NO301073B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D497/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO932127A 1992-06-11 1993-06-10 Imidatderivater av farmasöytisk nyttige sulfamater med antikonvulserende virkning samt farmasöytiske preparater inneholdende slike derivater NO301073B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/896,936 US5258402A (en) 1992-06-11 1992-06-11 Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates

Publications (3)

Publication Number Publication Date
NO932127D0 true NO932127D0 (no) 1993-06-10
NO932127L NO932127L (no) 1993-12-13
NO301073B1 NO301073B1 (no) 1997-09-08

Family

ID=25407090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932127A NO301073B1 (no) 1992-06-11 1993-06-10 Imidatderivater av farmasöytisk nyttige sulfamater med antikonvulserende virkning samt farmasöytiske preparater inneholdende slike derivater

Country Status (12)

Country Link
US (1) US5258402A (no)
EP (1) EP0574256A1 (no)
JP (1) JPH06271580A (no)
KR (1) KR100241860B1 (no)
AU (1) AU659939B2 (no)
CA (1) CA2098076C (no)
FI (1) FI109701B (no)
HU (1) HU219453B (no)
MX (1) MX9303477A (no)
NO (1) NO301073B1 (no)
NZ (1) NZ247786A (no)
SG (1) SG63549A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998380A (en) 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
KR970027051A (ko) * 1995-11-02 1997-06-24 조규향 카바모일기를 포함하는 신규한 설파메이트 화합물
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
IN190975B (no) 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
NZ514812A (en) * 1999-04-08 2005-01-28 Ortho Mcneil Pharm Inc Anticonvulsant derivatives useful in lowering blood pressure
AU782344C (en) * 1999-04-08 2006-08-17 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
DE60023910T2 (de) * 1999-07-26 2006-07-20 Ortho-Mcneil Pharmaceutical, Inc. Trizyklisch-monosaccharid-derivative verwendbar bei der behandlung von akuten ischamisch-induzierten neurodegenerationen
CA2477923C (en) 2002-03-01 2021-02-23 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
KR20050062976A (ko) * 2003-12-19 2005-06-28 일동제약주식회사 2,3:4,5-비스-오-(1-메틸에틸리덴)-베타-디-프럭토피라노즈설파메이트의 새로운 개량된 제조방법
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200612905A (en) * 2004-06-16 2006-05-01 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
ES2310366T3 (es) * 2004-08-24 2009-01-01 Janssen Pharmaceutica Nv Nuevos derivados de heteroaril sulfonamida benzo-condensada utiles como agentes anticonvulsivos.
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
CA2592320C (en) * 2004-12-22 2015-11-24 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
JP2008545650A (ja) * 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US20070155824A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US20070191451A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
US20070191460A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
US20070232556A1 (en) * 2006-03-31 2007-10-04 Montine Thomas J Methods and compositions for the treatment of neurological diseases and disorders
WO2007137167A2 (en) * 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
WO2008019394A2 (en) * 2006-08-11 2008-02-14 The Government Of The United States Of America As Represented By The Secretary, Dept Of Health And Human Services Methods for treatment and diagnosis of psychiatric disorders
SI2061458T1 (sl) * 2006-09-15 2015-04-30 Regents Of The University Of Minnesota Sestavki topiramata in metode za njihovo uporabo
US20090239942A1 (en) * 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
PE20110060A1 (es) 2008-06-23 2011-01-31 Janssen Pharmaceutica Nv Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US20110244057A1 (en) * 2008-09-25 2011-10-06 Ehrenberg Bruce L Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
WO2010035261A2 (en) 2008-09-29 2010-04-01 Ben Gurion University Of The Negev Research And Development Authority Amyloid beta-peptides and methods of use thereof
WO2014002678A1 (ja) 2012-06-29 2014-01-03 三菱電機株式会社 ロボット制御装置およびロボット制御方法
US20230137562A1 (en) 2017-06-07 2023-05-04 Adrx, Inc. Tau aggregation inhibitors
AU2018318319A1 (en) 2017-08-18 2020-02-20 Adrx, Inc. Tau aggregation peptide inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997585A (en) 1974-12-30 1976-12-14 Ortho Pharmaceutical Corporation Aliphatic sulfamates
US4459601A (en) 1981-01-30 1984-07-10 Exxon Research And Engineering Co. Ink jet method and apparatus
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4792569A (en) 1987-08-27 1988-12-20 Mcneilab, Inc. Anticonvulsant phenethyl sulfamates
US5242942A (en) 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates

Also Published As

Publication number Publication date
JPH06271580A (ja) 1994-09-27
US5258402A (en) 1993-11-02
HU9301715D0 (en) 1993-09-28
EP0574256A1 (en) 1993-12-15
KR940005633A (ko) 1994-03-22
CA2098076C (en) 2004-08-31
AU4006693A (en) 1994-02-03
CA2098076A1 (en) 1993-12-12
NZ247786A (en) 1994-10-26
MX9303477A (es) 1994-05-31
HUT69175A (en) 1995-08-28
HU219453B (hu) 2001-04-28
KR100241860B1 (ko) 2000-03-02
AU659939B2 (en) 1995-06-01
FI932655L (fi) 1993-12-12
FI932655A0 (fi) 1993-06-10
SG63549A1 (en) 1999-03-30
NO301073B1 (no) 1997-09-08
FI109701B (fi) 2002-09-30
NO932127L (no) 1993-12-13

Similar Documents

Publication Publication Date Title
NO932127D0 (no) Imidatderivater av farmasoeytisk nyttige antikonvulserendesulfamater
LV10099A (lv) Bicikliski heterocikliski atvasinajumi
FI930208L (fi) Kinazolinderivat
FI935431A7 (fi) Kiantsoliinijohdannaisia
FI980341A7 (fi) 2-oksi-indolijohdannaisia
NO921976D0 (no) Amidestere av rapamycin
NO921217D0 (no) Silyletere av rapamycin
ATA75293A (de) Indolderivate
FI933037A7 (fi) Tiazolylvinylfenylderivat
FI951004A0 (fi) Substituoidut tiatsolidiinidionijohdannaiset
FI893443A7 (fi) Derivat av n-fenylpyrazoler.
FI20031381A7 (fi) Menetelmä antihistamiinisten 4-difenyylimetyylipiperidiinijohdannaisten valmistamiseksi
FI941423A7 (fi) 17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset
DE69330497D1 (de) Chinazolin-derivate
FI20010214L (fi) Asyyliaminoindolijohdannaisia
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI20002460A7 (fi) 4-difenyylimetyylipiperidiinijohdannaisia
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
FI902028A7 (fi) Hydantoiinijohdannaisia
MX9204370A (es) Derivados de pirazol.
FI930367L (fi) Puridinderivat
FI922716L (fi) Foerfarande i samband med framstaellning av plaststycken
FI930922A7 (fi) Substituerade fenylkinazolinderivat
FI930934L (fi) Tetrahydropyrimidinderivat

Legal Events

Date Code Title Description
MK1K Patent expired